Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome

NCT05691582 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT05691582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05691582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome
Lead sponsor
IRCCS Eugenio Medea
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
April 15, 2022
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rett syndrome